Global Safety Syringes Market is valued at approximately USD 7096.94 million in 2022 and is anticipated to grow with a healthy growth rate of more than 4.5% during the forecast period 2023-2030.

MIT engineers have developed a tiny implantable device that could revolutionize emergency treatment for people with Type 1 ...

The North America Syringe Infusion Pumps Market is projected to grow from USD 645.1 million in 2024 to USD 1.04 billion by ...

The global safety syringes market, valued at approximately USD 7.1 billion in 2022, is projected to grow at a steady compound annual growth rate (CAGR) of over 4.5% during the forecast period from ...

Embecta Corp. (NASDAQ:EMBC) is one of the 13 Cheap Healthcare Stocks with Huge Upside Potential. On May 23, Mizuho lowered ...

A Leicestershire care service has been deemed unsafe after failing its first ever inspection. Healthcare watchdog the Care ...

Yesafili, a biosimilar to Eylea, received Health Canada's approval, marking the first such approval in Canada. Indicated for ...

New data from a Phase 3 trial show that the daily anti-obesity pill may be as safe and effective as drugs like Mounjaro and Ozempic for weight loss and lowering blood sugar.

TORONTO, Ontario, Canada and BENGALURU, Karnataka, India, June 27, 2025 (GLOBE NEWSWIRE) -- Biocon Biologics Ltd. (BBL), a ...

Biocon Biologics secures Health Canada approval for Yesafili, the first biosimilar to Eylea® in Canada, with a global launch ...

The global enteral feeding devices market, valued at US$2,807.9 million in 2024, stood at US$2,965.1 million in 2025 and is ...

They look convincing and promise results, but these counterfeit drugs caught at the border are putting Aussies at serious ...